ALLMedicine Prostatitis Center

Jun 2nd, 2020 - We conducted a review of the literature describing the most up-to-date diagnosis and treatment options of chronic bacterial prostatitis. Recurrence after oral antimicrobial therapy is common, due in part to the rising rates of antimicrobial resist...

May 7th, 2020 - Emphysematous prostatitis is a rare, clinical condition characterized by gas and abscess formation in the prostate often associated with features of sepsis. We report a case of 60-year-old gentleman presenting with emphysematous prostatitis compli...

May 5th, 2020 - Urologic chronic pelvic pain syndrome (UCPPS) is a chronic, noncyclic pain condition which can lead to significant patient morbidity and disability. It is defined by pain in the pelvic region, lasting for greater than 3 to 6 months, with no readil...

Apr 15th, 2020 - To evaluate and identify baseline factors associated with change in health-related quality of life (HRQOL) among patients with interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). A t...

Apr 13th, 2020 - The purpose of this study was to evaluate the biopsy histology of men who underwent transperineal multi-parametric magnetic resonance imaging (mpMRI)/transrectal ultrasound fusion biopsy for Prostate Imaging Reporting and Data System (PI-RADS) sco...

Jun 2nd, 2020 - We conducted a review of the literature describing the most up-to-date diagnosis and treatment options of chronic bacterial prostatitis. Recurrence after oral antimicrobial therapy is common, due in part to the rising rates of antimicrobial resist...

Jun 1st, 2020 - Ciprofloxacin tablet is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Inf...

May 31st, 2020 - Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Infections...

May 14th, 2020 - Ciprofloxacin tablet is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Inf...

May 7th, 2020 - CIPRO is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: •Skin and Skin Structure Infections (1.1) ...

Nov 6th, 2019 - NEW YORK (Reuters Health) - Few individual therapies provide meaningful reduction of symptoms in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), according to a systematic review. "Considering that we summarized the evidence of...

May 1st, 2016 - The incidence of true urinary tract infection (UTI) in adult males younger than 50 years is low (approximately 5-8 per year per 10,000), with adult females being 30 times more likely than males to develop a UTI. The incidence of UTI in males appro...

Dec 27th, 2015 - What Is Causing the Chest Pain? A 67-year-old man presents with severe chest pain radiating down both his arms. He has been in good health until the past 2 months, when he was diagnosed with and treated for gastroesophageal reflux and, more recent...

Oct 9th, 2015 - SAN DIEGO – Oral fosfomycin, a drug used for more than 4 decades to treat urinary tract infections in women, has gained a new life as a promising treatment for chronic prostatitis. In the largest patient series reported to date, a 6-week course of.

Sep 21st, 2015 - SAN DIEGO — High cure rates can be achieved with fosfomycin in patients with chronic prostatitis — many of whom are resistant to the current first-line treatment of fluoroquinolones — according to results from a new study. "For us, it's an alterna...